Introduction
Despite the identification of the causal agent of type B posttransfusion (serum) hepatitis,' and the subsequent removal of blood identified as positive for HBsAg by counterelectrophoresis (C.E.P.) hepatitis continues to complicate the therapeutic use of blood and blood products.2 More sensitive serological tests for surface antigen might lead to a reduction in the number of cases of post-transfusion hepatitis but are unlikely to eliminate it completely because of the potential infectivity of blood containing antibody to the Dane particle core3 and the possible existence of a reputed hepatitis C virus" -quite apart from other causes such as hepatitis virus A (infectious hepatitis) and other microbial agents. 5 The relatively insensitive technique of C.E.P.6 is most commonly used in blood banks. Much more sensitive assays, using principles of haemagglutination or radioimmunoassay, are now commercially available.
Some reports suggest that these kits can detect carriers of HBsAg too weak to be positive on C.E.P. Unfortunately, their effective use in the blood transfusion service will prove expensive and only time will tell whether such expense is justified.
We report here the experience of three Scottish blood transfusion centres in evaluating a sensitive and economical tannedcell haemagglutination-inhibition test (E.H.A.I.)."1 In addition to a field assessment involving 70 224 blood donations the test was compared with commercial haemagglutination and radioimmunoassay kits for specificity and sensitivity. We also present data on the retesting of 138 blood donors' sera which were HBsAg negative on initial screening by C.E.P. but were later implicated in post-transfusion hepatitis in 10 patients.
Methods
Haemagglutination Inhibition.-The test used was the "mini-micro" version of that described by Hopkins and patients were antigen positive) showed that in two cases an antigenpositive unit of blood had been transfused which was undetectable by the electrophoresis method during the initial screening as well as on reinvestigation. In both cases antigen was detected only by the more sensitive tests (table IV) . On reinvestigation of the two cases from Manchester (cases 9 and 10) a positive unit was detected in both cases, though one was missed by turkey cells and the other by Ausria I. The antigen-positive unit transfused in case 9 was subtyped as ad, while that transfused in case 10 was found to be ay, confirming the finding of the titration study (table II) 
